Computational psychiatry and genomics in the Michaelson lab
We are interested in the use of computing to improve the understanding, diagnosis, monitoring, and treatment of neuropsychiatric and neurodevelopmental conditions. We use a variety of data modalities: genomic, metabolic, pharmacological, medical record, imaging, audio recording, textual, and body movement to build predictive models that assist us in our mission of improving mental health through computing. We have extramurally-supported research programs involving computational methodology, animal models, and human subjects research.
Currently, our research focal areas are:
Non-coding genetic variation in brain development and function: the goal of this NIMH-supported project is to develop software tools that enable the estimation of when and where in the development of the brain non-coding genetic variants are likely to have an impact. Currently, non-coding genetic variation remains an important but poorly understood aspect of human medical genetics. Our efforts in this area will help to illuminate the role of non-coding variation in human brain development and help scientists better interpret genomic data.
Genetics of language impairment: in this NIDCD/NICHD-supported project, we are performing whole-genome sequencing of a cohort of Iowa children with language impairment (collected by UI collaborator Bruce Tomblin), where we hope to identify genes and mutations involved in the acquisition and use of language. We hope that research in this area will eventually help to further refine the categorization of language pathology so that therapies can be more targeted and effective.
Transcriptional and pharmacological regulation of hippocampal neurogenesis: In this BBR Foundation-supported project, we use mouse models to investigate the role of the transcription factors NPAS3 (implicated in human mental illness, including schizophrenia) and NPAS1 in adult hippocampal neurogenesis using RNA-seq and ChIP-seq. In addition, we are investigating the transcriptome-wide response induced by treatment with the neuroprotective compound P7C3. The findings of this project will yield a better understanding of the on and off-target effects of the drug P7C3, as well as its mechanism of action, and a better understanding of the NPAS3 regulatory cascade. This project is being performed in close collaboration with the lab of Andrew Pieper.
Genetics of autism: we recently joined SPARK, the Simons Foundation's effort to recruit 50,000 individuals with autism and their families. This effort will provide an unparalleled resource for autism researchers and the autism community.
Other areas of interest include machine learning in the context of genomics, sex-by-genotype interactions and sex-specific effects in neurodevelopment, and translational genetics. We are constantly forming on and off-campus collaborations to further these and other areas of interest.
Jacob J. Michaelson, PhD, professional profile